Outcome
    Strong Evidence
    Effectiveness 4/5

    Zinc for Diarrhea Prevention

    Zinc is a WHO-recommended intervention for childhood diarrhoea and is one of the highest-impact nutritional treatments in global health.

    Overview

    Zinc for diarrhoea is one of the strongest evidence stories in nutritional medicine, and it is also one of the most context-dependent. In children under five in low- and middle-income settings, where zinc deficiency is common, supplementation shortens acute diarrhoea by roughly a day and reduces the chance of a further episode over the following two to three months. The WHO and UNICEF recommend it as standard care alongside oral rehydration. That evidence does not transfer cleanly to well-nourished adults in high-income countries, where zinc status is usually adequate and trial data are sparse. The pairing is strongly supported where deficiency is plausible and largely untested where it is not.

    Verdict

    Strong yes

    Cochrane-level evidence supports zinc for reducing duration and recurrence of acute diarrhoea in children over six months in settings where deficiency is common. Evidence in well-nourished adults is limited.

    How It Works

    Zinc acts directly on intestinal transport. It inhibits cyclic-AMP-dependent chloride secretion — the pathway hijacked by cholera and enterotoxigenic E. coli — while enhancing sodium and water absorption, which shifts net fluid movement back toward the bloodstream. That is the acute anti-secretory effect. Over a longer horizon zinc supports mucosal repair and immunity. It is a cofactor for enterocyte proliferation and brush border enzyme activity, it strengthens tight junctions, and it is required for lymphocyte development and secretory IgA production. Correcting deficiency therefore reduces susceptibility to the next infection, which is the mechanism behind the recurrence benefit.

    Pathways involved

    Inhibition of cAMP-mediated chloride secretion
    Enhanced sodium and water absorption
    Enterocyte proliferation and mucosal repair
    Brush border enzyme activity
    Tight junction integrity
    Lymphocyte function and secretory IgA

    Dosing & Protocol

    ScenarioDoseFormTiming
    Children 6 months to 5 years (WHO)20 mg elemental dailySulphate, acetate or gluconateDaily for 10-14 days
    Infants under 6 months (WHO)10 mg elemental dailySulphate or gluconateDaily for 10-14 days
    Adult short-term use15-25 mg elemental dailyGluconate or picolinateWith food, short courses
    Long-term adult ceiling40 mg elemental dailyAnyUpper tolerable limit
    1. 1

      Rehydration comes first· Immediately

      Oral rehydration solution is the intervention that prevents death from diarrhoea. Zinc is an adjunct to it, never a replacement.

    2. 2

      Use the WHO course in children· Days 1-14

      20 mg elemental daily for 10 to 14 days for children over six months, started at the onset of the episode.

    3. 3

      Take with food if nausea occurs· Each dose

      Zinc on an empty stomach commonly causes nausea and vomiting, which is self-defeating during diarrhoea.

    4. 4

      Keep adult courses short· Ongoing

      Weeks, not months. Sustained intake above 40 mg daily induces copper deficiency.

    5. 5

      Seek care for red flags· Any time

      Blood in stool, high fever, signs of dehydration, or diarrhoea lasting more than a few days need medical assessment.

    Context sets the expectation

    The large benefit comes from trials in children where zinc deficiency is prevalent. A well-nourished adult in a high-income country should expect a much smaller effect, if any, and there is little trial evidence to guide use.

    Evidence

    Cochrane reviews of zinc for acute diarrhoea in children report a reduction in episode duration of roughly 10 to 12 hours overall, with larger effects — around a day — in children over six months and in populations with high deficiency prevalence. Trials also show fewer episodes over the subsequent two to three months, which is the prevention endpoint relevant here. The picture in infants under six months is different, with no clear benefit and some evidence of increased vomiting, and the evidence base in adults is thin. No individual trials are linked to this pairing in our database yet, so this summary reflects the wider literature rather than pair-specific citations.
    Best available evidence
    Cochrane reviews of zinc for acute diarrhoea in children
    Typical effect
    Around one day shorter episodes and fewer recurrences over 2-3 months
    Where benefit is clearest
    Children over 6 months in deficiency-prevalent settings
    Where evidence is weak
    Infants under 6 months; well-nourished adults
    Certainty of evidence
    Moderate to high in the target population

    Safety

    Copper is the long-term risk

    Sustained intake above 40 mg elemental daily interferes with copper absorption and can cause copper-deficiency anaemia and neurological problems. Keep high-dose zinc to defined short courses.

    Common effects

    Nausea and vomiting, especially on an empty stomach
    Metallic taste
    Abdominal discomfort
    Copper deficiency with prolonged high dosing
    Reduced immune function at very high chronic intake

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Copper
    moderate
    Zinc induces metallothionein, which traps copper in enterocytesAvoid prolonged doses above 40 mg daily; consider copper if long-term use is unavoidable
    Tetracycline and quinolone antibiotics
    moderate
    Mutual chelation reduces absorption of bothSeparate by at least 2 hours before or 4-6 hours after
    Iron supplements
    low
    Competition for shared absorption pathwaysTake at different times of day
    Penicillamine
    moderate
    Reduced drug efficacy through chelationSeparate doses by several hours
    Thiazide diuretics
    low
    Increased urinary zinc lossNo action usually needed; relevant on long-term therapy

    References

    1. Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2016
    2. WHO/UNICEF Joint Statement: Clinical Management of Acute Diarrhoea. 2004

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.